How is sleep quality in IBD patients?
Sleep quality in patients with inflammatory bowel disease (IBD) is generally poorer compared to healthy individuals. Studies from several regions and using both objective and subjective measures consistently demonstrate a high prevalence of sleep disturbances among IBD patients, even during periods of clinical remission. For example, large cross-sectional and prospective studies indicate rates of poor sleep ranging from approximately 32% up to 75%, depending on disease activity and population sampled[1] [2] [3] [4].
Prevalence and Patterns
Multiple multicenter and population-based studies report that around 60%–75% of IBD patients have a Pittsburgh Sleep Quality Index (PSQI) score indicative of poor sleep quality, and this rate is higher during active disease phases[2] [5] [6] [7]. Sleep problems remain common even in patients whose IBD is in remission, though severity is often greater in those with active disease[8] [9].
Objective assessments like actigraphy and polysomnography also demonstrate disrupted sleep architecture, increased sleep fragmentation, and reduced sleep efficiency in IBD patients, including those in remission or with inactive disease[10] [11] [12]. Some specific patterns observed include higher rates of nocturnal awakenings, longer sleep latency, and more time spent awake after sleep onset compared to controls[5] [10] [13].
Risk Factors and Determinants
Several factors are consistently linked to poorer sleep quality in IBD:
- Disease activity: Increased sleep problems are observed in patients with active or more severe disease[5] [14] [15].
- Mood disorders: Anxiety and depression are common in IBD and are independently associated with poor sleep[2] [6] [7] [16].
- Older age and comorbid conditions: Older IBD patients and those with comorbidities report worse sleep[2] [6].
- Treatment factors: Use of certain medications (e.g., corticosteroids, opioids) is associated with impaired sleep[17].
- Inflammatory burden: Biomarkers of inflammation correlate with sleep problems, suggesting a bidirectional relationship between poor sleep and IBD activity[18] [15].
Consequences and Clinical Impact
Impaired sleep is associated with increased risk of disease flares, hospitalization, and worse quality of life in IBD patients[4] [19] [20]. Fatigue is a prominent symptom linked with sleep disturbances, even when disease is under control[10] [21] [22]. Additionally, poor sleep can exacerbate mood symptoms, pain, and overall functional impairment[7] [23].
Interventions and Management
Some interventions, such as continuous nursing care, digital health programs, washed microbiota transplantation, and medical cannabis, have shown promise in improving sleep quality in IBD patients, with subsequent positive effects on quality of life[24] [25] [26] [27]. However, access to behavioral sleep medicine and sleep-focused interventions remains limited for many patients[4].
In summary, poor sleep quality is a very common and clinically significant problem in IBD, affecting a majority of patients at some stage. Its severity tends to correlate with active disease and with psychological distress. Sleep problems should be routinely screened for and integrated into comprehensive IBD management, as improving sleep quality may positively impact disease outcomes and patient well-being[3] [4] [10] [5] [2] [14] [7] [24] [17] [8] [15] [11] [19].
Would you like details on specific interventions, the pathophysiological mechanisms linking IBD and sleep, or pediatric populations? Or is there another aspect of this topic you would like to explore further?